Kentucky Women's Justice Community Overdose Innovation Network - Phase II

ConditionsOverdose Risk Opioid Use Disorder Stimulant Use Disorders

Trial statusRecruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexFemale

Age18+

SponsorMichele Staton

About this trial

This project continues our work with women in the Kentucky Women's Justice Community Overdose Innovation Network Phase II (WJCOIN-II) with the overall aim of reducing overdose risk during the transition from jail to rural communities. WJCOIN-II has potential for significant impact regarding the effectiveness, implementation, and sustainability of innovative overdose prevention strategies during the high-risk time of community re-entry among vulnerable, CLS-involved women in rural communities. This research will impact the field by increasing the capacity of the criminal legal system to respond to the overdose crisis through increased access to prevention strategies to reduce overdose risk.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

DSM-5 scores of 2+ for opioids (OUD) and/or stimulants (StUD),

no evidence of cognitive impairment in providing consent,

a release date within 7-60 days to allow for time for intervention sessions,

willingness to consider SUD treatment post-release, and

Disqualifiers

Not living in a rural area

Any condition that would not allow capable informed consent

Trial design

Design model

Factorial

Treatments tested in this trial

Overdose Prevention Intervention Package (OPIP)
Behavioral
WJCOIN-II's multi-level 2 X 2 randomized factorial design will examine the effectiveness of OPIP components across four study conditions randomly assigned after baseline data collection (n=75 per condition, 100 per jail site), summarized in Table 7 and described below. In addition to group assignment, outcomes will be assessed as a function of engagement in each intervention component defined as the number of sessions attended (RC and CM conditions) and perceived support, which is a count of the number of types of support provided by the RC and SP (e.g., emotional, financial, etc.).

Treatment groups

300 Participants

are divided into 4 treatment groups

Group A: Recovery Coaching OnlyExperimental treatment 1 intervention

Group B: Recovery Coaching + Safe Person EngagementExperimental treatment 1 intervention

Group C: Recovery Coaching + Contingency ManagementExperimental treatment 1 intervention

Group D: Recovery Coaching + Support Person Eng + Contingency ManagementExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

Overdose risk

Overdose risk score based on days of opioid, stimulant, and polysubstance use

Time frame

3, 6, and 12 months post-release

Treatment entry

Entry into any formal ASAM level of SUD treatment (e.g., outpatient, intensive outpatient, residential, inpatient, MOUD) (yes/no)

Time frame

1 month postrelease

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Michele Staton

Lead sponsor

University of Kentucky

Sponsor institution

National Institute on Drug Abuse (NIDA)

Collaborator

Source ClinicalTrials.gov

Apply now